Dow Tumbles 200 Points; Liquidity Services Shares Spike Higher

Benzinga12-13

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 200 points on Thursday.

The Dow traded down 0.46% to 43,947.18 while the NASDAQ fell 0.38% to 19,957.81. The S&P 500 also fell, dropping, 0.34% to 6,063.38.

Check This Out: Jim Cramer Says ‘Keep Owning’ This Energy Stock, Abbott Laboratories ‘Legal Stuff’ Is Behind Them

Leading and Lagging SectorsConsumer staples shares jumped by 0.5% on Thursday.

In trading on Thursday, health care shares fell by 0.5%.

Top Headline

Shares of Ciena Corp (NYSE:CIEN) jumped more than 15% on Thursday after the company released fourth-quarter results.

The company reported a fiscal fourth-quarter 2024 revenue decline of 0.5% year-on-year to $1.124 billion, beating the analyst consensus estimate of $1.104 billion. The American telecommunications networking equipment and software services supplier reported adjusted EPS of 54 cents, missing the analyst consensus estimate of 66 cents.

Equities Trading UP                       

  • Liquidity Services, Inc. (NASDAQ:LQDT) shares shot up 32% to $34.02 after the company reported better-than-expected fourth-quarter financial results.
  • Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) got a boost, surging 72% to $4.28 after the company announced positive outcomes for the treatment of patients from its chronic cough Phase 2b CORAL trial.
  • 3D Systems Corporation (NYSE:DDD) shares were also up, gaining 21% to $4.07 after the company inked a definitive agreement to sell its Geomagic software portfolio to Hexagon's Manufacturing Intelligence Division for $123 million.

Equities Trading DOWN

  • Sacks Parente Golf, Inc. (NASDAQ:SPGC) shares dropped 74% to $0.37 after the company priced an upsized $8.4 million underwritten public offering of 7 million common units at $1.20 per unit.
  • Shares of Keros Therapeutics, Inc (NASDAQ:KROS) were down 74% to $18.12 after the company announced it halted treatment in the 3.0 mg/kg and 4.5 mg/kg arms of its ongoing TROPOS trial due to safety concerns..
  • The Lovesac Company (NASDAQ:LOVE) was down, falling 27% to $27.38 after the company reported mixed third-quarter financial results.

CommoditiesIn commodity news, oil traded up 0.1% to $70.38 while gold traded down 1.7% at $2,709.40.

Silver traded down 4.1% to $31.630 on Thursday, while copper fell 0.6% to $4.2400.

Euro zone

European shares were mixed today. The eurozone's STOXX 600 fell 0.14%, Germany's DAX rose 0.13% and France's CAC 40 fell 0.03%. Spain's IBEX 35 Index slipped 0.21%, while London's FTSE 100 rose 0.12%.

Asia Pacific Markets

Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 gaining 1.21%, Hong Kong's Hang Seng Index gaining 1.20%, China's Shanghai Composite Index gaining 0.85% and India's BSE Sensex falling 0.29%.

Economics

  • U.S. initial jobless claims increased by 17,000 from the previous week to a reading of 242,000 during the first week of December, compared to market estimates of 220,000.
  • Core producer prices increased by 0.2% month-over-month in November compared to a 0.3% increase in the previous month and in-line with market expectations.
  • U.S. natural-gas stocks fell 190 billion cubic feet to 3.747 trillion cubic feet in the week ended Dec. 6, compared to market estimates of a 170 billion cubic feet decline.

Now Read This:

  • Wall Street’s Most Accurate Analysts Weigh In On 3 Risk Off Care Stocks With Over 5% Dividend Yields
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment